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The behavioural phenotype of Potocki-
Lupski syndrome: a cross-syndrome
comparison
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Abstract
Background: Potocki-Lupski syndrome (PTLS) and Smith-Magenis syndrome (SMS) are related genomic disorders,
as duplication 17p11.2 (associated with PTLS) is the reciprocal recombination product of the SMS microdeletion.
While SMS has a relatively well-delineated behavioural phenotype, the behavioural profile in PTLS is less well
defined, despite purported associations with autism spectrum disorder (ASD) and the suggestion that some
behaviours may be diametric to those seen in SMS.
Methods: Caregivers of individuals with PTLS (N = 34; M age = 12.43, SD = 6.78) completed online behavioural
questionnaires, including the Challenging Behaviour Questionnaire (CBQ), the Activity Questionnaire (TAQ), the
Repetitive Behaviour Questionnaire (RBQ), the Mood, Interest and Pleasure Questionnaire-Short Form (MIPQ-S) and
the Social Communication Questionnaire (SCQ), which assesses behaviours associated with ASD. Individuals with
PTLS were matched on age and adaptive functioning to individuals with SMS (N = 31; M age = 13.61, SD = 6.85) and
individuals with idiopathic ASD (N = 33; M age = 12.04, SD = 5.85) from an existing dataset.
Results: Individuals with PTLS and SMS were less impaired than those with idiopathic ASD on the communication and
reciprocal social interaction subscales of the SCQ, but neither syndrome group differed from idiopathic ASD on the
restricted, repetitive and stereotyped behaviours subscale. On the repetitive behaviour measure, individuals with PTLS
and idiopathic ASD scored higher than individuals with SMS on the compulsive behaviour subscale. Rates of self-injury
and property destruction were significantly lower in PTLS and idiopathic ASD than in SMS. No between-syndrome
differences were found in relation to overactivity or mood; however, impulsivity was greater in SMS than in PTLS.
Conclusions: Findings suggest some overlap in the behavioural phenotype of PTLS and features of ASD
symptomatology; however, the overall profile of behaviours in PTLS appears to be divergent from both idiopathic ASD
and SMS. Relative to idiopathic ASD, PTLS is not characterised by communication or social interaction deficits. However,
restricted and repetitive behaviours were evident in PTLS, and these may be characterised specifically by compulsive
behaviours. While several behavioural differences were identified between PTLS and SMS, there was little evidence of
diametric behavioural phenotypes, particularly in relation to social behaviour.
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Background
Potocki-Lupski syndrome (PTLS) occurs in approximately
1 in 25,000 births [1] and is associated with congenital
anomalies and intellectual disability (ID) [2]. PTLS is
caused by genetic duplication within the 17p11.2 region,
which comprises low copy repeat (LCR) gene clusters
known as SMS-REPs [3, 4]. The proximal and distal SMS-
REPs located on chromosome 17p11.2 are areas of genetic
instability that are highly susceptible to non-allelic hom-
ologous recombination [5]. Although PTLS is most com-
monly associated with a ~ 3.7-Mb duplication, larger and
smaller duplications have also been reported [1, 6]. Dupli-
cation of PMP22 at 17p12 causes Charcot-Marie-Tooth
disease type 1A (CMT1A) [6]. Large duplications that
encompass both the PTLS region at 17p11.2 and PMP22
have been reported, and the resulting clinical phenotype is
termed Yuan-Harel-Lupski syndrome (YUHAL) [7]. PTLS
is characterised by poor feeding in infancy, infantile hypo-
tonia, cognitive impairment, cardiovascular abnormalities
and speech and language impairment [1, 6, 8, 9], whereas
the YUHAL phenotype is typically more severe, in relation
to motor delay and onset of clinical neuropathy [7].
It has been difficult to ascertain whether there is a dis-
tinctive behavioural phenotype associated with PTLS
(the subset of behaviours that occur more often in indi-
viduals with the disorder than in individuals without the
disorder [10]), because it is a recently recognised syn-
drome [1], and the PTLS duplication cannot easily be
detected using cytogenetic analysis. Clinical case reports
have documented repetitive behaviours and vocalisa-
tions, anxiety, hyperactivity, attention deficits and behav-
ioural problems in some individuals with PTLS [11–13].
Two larger scale multidisciplinary studies have been
conducted to delineate the behavioural profile of PTLS
[1, 14], in which repetitive behaviours, hyperactivity,
anxiety, withdrawal and inattention and behaviours asso-
ciated with autism spectrum disorder (ASD) were de-
scribed. However, the extent to which these behaviours
can be considered phenotypic is limited, due to the
absence of comparison groups, which are required to
establish whether behaviours are more likely in a given
syndrome.
PTLS duplications are the reciprocal recombination
products of the Smith-Magenis syndrome (SMS) micro-
deletions. The dosage-sensitive retinoic acid inducible 1
(RAI1) candidate gene is implicated in both PTLS and
SMS [6, 15]. RAI1 is associated with transcript regula-
tion, although it is unclear exactly how RAI1 deletions,
duplications or mutations relate to the clinical and be-
havioural manifestations in these genomic disorders
[16]. There is substantial overlap in the phenotype of in-
dividuals with SMS resulting from specific RAI1 point
mutations and those with SMS caused by 17p11.2 dele-
tions [17, 18], suggesting that the core features of SMS,
including most aspects of the neurobehavioural pheno-
type, are caused by haploinsufficiency of RAI1. The com-
mon clinical phenotype associated with SMS is mild to
moderate ID, hearing impairments, delayed speech, dys-
morphic facial features and cardiovascular and renal
abnormalities, amongst many others [17, 19–21]. Its be-
havioural phenotype is very distinctive; high prevalence
of self-injury and aggression, upper body hugging, re-
petitive page ‘lick and flip’, mouthing of hands or objects,
insertion of fingers and objects into other body orifices,
removal of fingernails and sleep difficulties due to an
inverted circadian rhythm of melatonin are well docu-
mented [4, 17, 19, 22, 23]. Some literature suggest larger
deletions can result in greater phenotypic severity in re-
lation to the behavioural phenotype [17, 24]; however,
this has not been substantiated in other clinical reports
[20]. Individuals with RAI1 point mutations as opposed
to 17p11.2 deletions are less likely to present with short
stature, cardiac anomalies and hearing problems and are
more likely to exhibit certain characteristics relating to
food intake, obesity, self-hugging and skin picking, for
example [17, 18]. Therefore, the role of RAI1 in these
phenotypic characteristics may depend on whether hap-
loinsufficiency of RAI1 is caused by a mutation versus a
deletion of this gene (and other genes in the 17p11.2 re-
gion). Interestingly, RAI1 overexpression in PTLS is also
believed to disrupt circadian gene expression resulting in
sleep difficulties, which suggests RAI1 is implicated in
the phenotype of both SMS and PTLS in this respect
[25].
Given the genetic relationship between PTLS and
SMS, it has been suggested that traits may be mir-
rored or diametrically opposed in these two syn-
dromes [26–28]. ‘Mirror traits’ are described by
Lupski [27] as aspects of a syndrome that are diamet-
ric or opposing to those seen in its related or sister
disorder (e.g. duplication and deletion recombination
reciprocal disorders) and is the term that will be
adopted here. Supporting evidence of diametric phe-
notypes comes from mouse models of PTLS and
SMS, in which mice with the common PTLS duplica-
tion display mirror traits (hyperactivity, impaired con-
textual fear conditioning and intact learning), in
comparison to mice with the common SMS deletion
(hypoactivity, an intact fear conditioning response and
marked learning deficits) [29–31], and from reports of
diametric levels of sociability between individuals with
PTLS and SMS (see [26] for a review). Compared to
PTLS, relatively good social skills are reported in the
SMS literature, such as maintained eye contact, high
levels of social engagement and a keen sense of
humour [32], which is offset by a significant prefer-
ence for adult attention as opposed to peer attention
[33, 34].
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Comparisons between PTLS and SMS may be inform-
ative on two levels. Clinically, contrasts with a well-
delineated syndrome provide families and professionals
with valuable context to anchor the severity, topography
and prevalence of behaviours seen in the individuals they
care for with PTLS. From a theoretical perspective,
cross-syndrome comparisons between PTLS and SMS
may help to elucidate genotype-phenotype correlations
between copy number variation at 17p11.2 and behav-
iour. In other genetic syndromes that share genetic
anomalies within the same region, it has been possible
to make such behavioural cross-syndrome comparisons.
Angelman syndrome (AS) and Prader-Willi syndrome
(PWS) are sister disorders, related to maternal and pa-
ternal genomic imprinting defects, respectively, within
the same 15q11–q13 region [35–37]. Despite this shared
genetic basis, distinctive behavioural phenotypes, or mir-
ror traits, are described in AS (frequent laughing and
smiling, repetitive stereotypies, overactivity) and PWS
(food-seeking behaviours, temper outbursts, impulsivity)
[35, 36, 38, 39].
However, evidence of mirrored behavioural traits is ten-
tative in PTLS, given that atypical sociability may not ne-
cessarily be phenotypic of the syndrome. It is particularly
difficult to identify ASD behaviours in individuals with
genetic syndromes associated with ID, as there may be
qualitative differences in ASD phenomenology between in-
dividuals with a genetic syndrome and individuals with
idiopathic ASD [40]. Although ASD behaviours have been
identified in several individuals with PTLS, studies report-
ing this vary in terms of whether they assess behaviours
using standardised measures [41] or whether behaviours
are described simply as ‘features’ characteristic of ASD
[12]. Furthermore, there are a number of PTLS case re-
ports, which explicitly state an absence of ASD behaviours
[42], and literature that also suggests individuals with PTLS
can show relative strengths in social interaction (e.g. joint
attention, appropriate play), which would not be indicative
of the behavioural profile seen in idiopathic ASD [14].
To establish whether atypical social behaviours are
associated with PTLS, it is also of clinical interest to
compare social behaviours to an idiopathic ASD group.
Therefore, the aim of the present study was to further
delineate the behavioural phenotype of PTLS via com-
parisons to two disorders: SMS and idiopathic ASD.
Methods
Recruitment and participants
Families were recruited primarily through two support
group organisations: Unique based in the UK and the
Potocki-Lupski Syndrome Outreach Foundation based
in the USA. All participants had received a diagnosis of
PTLS from a paediatrician, clinical geneticist, general
practitioner or neurologist. Data from five participants
could not be analysed, as fewer than 75% of question-
naire items had been completed and three participants
with an additional diagnosis of CMT1A were removed
from analysis.
Therefore, 34 individuals with PTLS were matched,
first according to level of adaptive ability as determined
by the self-help subscale of the Wessex Scale [43] (+/− 2
points) and then by age (+/− 2 years), to an idiopathic
ASD group and SMS group, derived from a database of
participants who have participated in previous research
and consented for their data to be used in future re-
search. Individuals with ASD had a confirmed diagnosis
from a relevant professional, paediatrician, general prac-
titioner, psychiatrist, clinical psychologist, or educational
psychologist, and the SCQ was used as an additional
screening measure. One individual from the idiopathic
ASD group and three individuals from the SMS group
could not be matched within two points and 2 years to
four individuals with PTLS, hence the unequal group
numbers. The data in Table 1 indicate that the groups
were relatively well matched according to age (H(2) =
1.153, p = .562) and level of ability (H(2) = .909, p = .635),
as p > .50 is arguably an appropriate value to assume
groups do not differ [44].
Table 1 Demographic information of each syndrome group and associated cross-syndrome comparisons and post hoc tests
Variables Syndrome group Cross-syndrome comparison
PTLS (N = 34) SMS (N = 31) ASD (N = 33) p value Post hoc test
Mean agea, years (SD) 12.43 (6.78) 13.61 (6.85) 12.04 (5.85) .562
% male (N) 55.88 (19) 45.16 (14) 87.88 (29) .001 ASD > SMS, PTLS
Mean self-help scorea, b (SD) 7.18 (1.47) 7.06 (1.34) 7.39 (1.43) .635
% fully mobileb (N) 79.41 (27) 77.42 (24) 90.91 (30) .369
% normal vision (N) 82.35 (28) 70.97 (22) 100.00 (33) .005 ASD > SMS
% normal hearing (N) 91.18 (31) 64.52 (20) 100.00 (33) < .001 ASD > SMS
% verbal/partly verbalc (N) 85.29 (29) 87.10 (27) 87.88 (29) .950
aContinuous non-normally distributed data; therefore, Kruskal-Wallis tests were conducted
bData derived from the Wessex Behaviour Schedule
cData derived from item 1 of the Wessex Behaviour Schedule—‘Is the person you care for verbal? (more than 30 signs/words in their vocabulary)’
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There were more males in the idiopathic ASD group
compared to the SMS group (χ2(1) = 13.231, p < .001)
and the PTLS group (χ2(1) = 8.439, p = .004). There were
also more individuals in the ASD group with normal vi-
sion (χ2(1) = 11.148, p = .001) and normal hearing (χ2(1)
= 13.075, p < .001), compared to the SMS group.
Procedure
Parents and caregivers of children and adults with PTLS
were invited via Unique and the Potocki-Lupski Syn-
drome Outreach Foundation to complete an online sur-
vey, created using LimeSurvey 2.00+ software. The
online survey included an information sheet, consent
forms and questionnaire measures.
Measures
Demographic questionnaire
Parents and caregivers reported on the gender, age, ver-
bal capacity, mobility and diagnosis of PTLS (such as
date of diagnosis and whether an additional diagnosis of
CMT1A has been made).
Wessex Behaviour Schedule [43]
This schedule measures the degree of ability in individ-
uals with ID. Only the ‘incapacities’ and ‘speech’ scales
were included in the present study, which measure as-
pects such as mobility, self-help capacity, vision and
hearing. Items are rated on a three-point scale from 1
(severe impairment) to 3 (no impairment). Inter-rater re-
liability of these subscales in the original Wessex Behav-
iour Schedule ranged from 78% (self-help skills, literacy)
to 92% (mobility) [43].
Social Communication Questionnaire (SCQ [45])
Higher scores on this 40-item measure denote greater
ASD symptomology, with a cut-off score of 15 indicative
of ASD. Thirty-six of the items are subdivided into three
domains, reciprocal social interaction, communication
and restricted, repetitive and stereotyped behaviours.
Parents and caregivers are asked to indicate the occur-
rence of behaviours over the person’s lifetime (e.g. ‘Has
she/he ever seemed to be unusually interested in the
sight, feel, sound, taste or smell of things or people?’)
and also between the ages of four and five. This measure
has good diagnostic validity, with sensitivity and specifi-
city values of .92 and .62, respectively, when a cut-off
score of 15 for ASD is utilised [46].
Repetitive Behaviour Questionnaire (RBQ [47])
Informants indicate the occurrence of 19 observable,
operationally defined behaviours (e.g. hoarding, repetitive
questions, lining up or arranging objects), which can be
grouped according to five domains of repetitive behaviour:
stereotyped behaviour, compulsive behaviour, insistence
on sameness, restricted preferences and repetitive speech.
Restricted preferences and repetitive speech are not calcu-
lated for individuals with limited verbal ability. Correlation
coefficient values of .46–.80 for inter-rater reliability and
.61–.93 for test-retest reliability have been attained [48].
Challenging Behaviour Questionnaire (CBQ [49])
The CBQ determines the presence of self-injurious, ag-
gressive, destructive and stereotyped behaviours, as well
as the topography, duration, consequence and frequency
of self-injurious behaviours in the last month, if applic-
able (e.g. rubs or scratches self ). Moderate to very strong
kappa coefficients [50] for the CBQ have been reported
in relation to inter-rater reliability (.60–.92) [49].
Mood, Interest and Pleasure Questionnaire-Short Form
(MIPQ-S [51])
The MIPQ-S is a 12-item measure; six items correspond
to a ‘mood’ subscale (e.g. ‘In the last two weeks, do you
think the facial expression of the person looked flat …’)
and six items correspond to an ‘interest and pleasure’
subscale (e.g. ‘In the last two weeks, did the person seem
to have been enjoying life …’). The MIPQ-S has good
psychometric properties in relation to inter-rater and
test-retest reliability, with correlation coefficient values
of .85 and .97, respectively [52].
The Activity Questionnaire (TAQ [53])
This measure is comprised of three subscales: impulsivity,
overactivity and impulsive speech. Impulsive speech is not
calculated for non-verbal individuals. Respondents are
asked to rate the frequency of 18 behaviours (e.g. ‘Does the
person want things immediately?’) according to a five-point
scale ranging from 0 (never/almost never) to 4 (always/al-
most all of the time). Mean inter-rater reliability and test-
retest reliability correlation coefficient values of .56 and .75,
respectively, have been reported [54].
Data analysis
Data were analysed using Statistical Package for Social
Sciences (SPSS) 20.0 software. Normality was assessed
via Shapiro-Wilk tests, analysis of skewness and kurtosis
and scrutiny of distribution plots for the identification of
outliers. Levene’s test was used to determine homogen-
eity of variance when applicable. Chi-square tests were
employed to compare categorical data between syn-
drome groups, and parametric one-way analyses of co-
variance or non-parametric Kruskal-Wallis tests were
conducted to compare continuous data between groups.
Significant group differences (set at p < .01 to control for
multiple group comparisons) were followed up with the
appropriate categorical (one-way chi-square test), para-
metric (independent t test) or non-parametric (Mann-
Whitney test) post hoc analyses (p < .01).
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Results
Prevalence of ASD behaviours and repetitive behaviours
The percentage of individuals from each syndrome
group who scored above the clinical cut-off score for
ASD is presented in Table 2. As expected, more individ-
uals with idiopathic ASD met the clinical cut-off score
for ASD than the PTLS group (χ2(1) = 14.188, p < .001)
or the SMS group (χ2(1) = 12.443, p < .001).
As shown in Table 3, individuals with idiopathic ASD
attained higher scores than the other groups on the re-
ciprocal social interaction subscale (SMS U(1) = 208.50,
Z = − 3.679, p < .001; PTLS U(1) = 205.50, Z = − 4.470, p
< .001) and communication subscale (SMS U(1) =
212.00, Z = − 3.628, p < .001; PTLS U(1) = 305.00, Z = −
3.221, p = .001) of the SCQ. These differences remained
even when verbal items (items 2–7) were removed from
analysis, indicating such differences were not due to
verbal ability affecting scores on the communication
subscale. Individuals with PTLS did not differ signifi-
cantly from those with SMS on either of these subscales
(reciprocal social interaction U(1) = 337.50, Z = − 1.968,
p = .049; communication U(1) = 403.00, Z = − 0.037, p
= .300). There were no statistically significant differ-
ences between groups on the restricted, repetitive and
stereotyped behaviour subscale of the SCQ (H(2) =
5.259, p = .072).
There were no overall between-group differences iden-
tified on the majority of the RBQ subscales (stereotyped
behaviour H(2) = 6.775, p = .034; insistence on sameness
H(2) = 8.472, p = .014; restricted preferences H(2) = .413,
p = .814; repetitive speech H(2) = 2.191, p = .334), which
was due to the utilisation of a more stringent adjusted p
value for some of the subscales (e.g. stereotyped behav-
iour and insistence on sameness). However, a marked
between-group difference was found for compulsive be-
haviour (H(2) = 16.613, p < .001). On this subscale, indi-
viduals with PTLS showed higher levels of compulsive
behaviour than individuals with SMS (U(1) = 263.50, Z =
− 3.481, p = .001), as did individuals with idiopathic ASD
(U(1) = 243.50, Z = − 3.616, p < .001). No significant dif-
ference in compulsive behaviour was found between
individuals with PTLS and individuals with ASD how-
ever (U(1) = 552.50, Z = − .107, p = .915).
Self-injury, aggression, mood, interest and pleasure,
overactivity and impulsivity
Groups differed on a number of specific CBQ items as
shown in Table 4. Individuals with SMS were more likely
to display self-injurious behaviour than individuals with
PTLS (χ2(1) = 27.793, p < .001) or individuals with idio-
pathic ASD (χ2(1) = 20.780, p < .001). Scores of individ-
uals with PTLS were not significantly different from
those with idiopathic ASD (χ2(1) = .740, p = .390). Indi-
viduals with SMS were also more likely to show destruc-
tion of property than individuals with PTLS (χ2(1) =
18.841, p < .001) or individuals with idiopathic ASD
(χ2(1) = 7.458, p = .006). Again, individuals with PTLS
did not differ from individuals with idiopathic ASD
(χ2(1) = 3.003, p = .082). However, groups did not differ
on rates of physical aggression (χ2(2) = 2.269, p = .322)
and did not differ on severity of self-injurious behaviour
(H(2) = .223, p = .894), according to the CBQ.
Median subscale scores attained by each syndrome
group on behavioural measures relating to mood, inter-
est and pleasure, overactivity and impulsivity are also
presented in Table 3 (except for the interest and pleasure
subscale of the MIPQ-S, for which the mean group
scores and 95% confidence intervals are reported). On
the MIPQ-S, individuals with PTLS showed higher levels
of interest and pleasure compared to individuals with
idiopathic ASD (t(65) = − 3.125, p = .003) but not indi-
viduals with SMS (t(63) = − .870, p = .388). Individuals
with SMS did not differ significantly from those with
idiopathic ASD (t(62) = 2.128, p = .037). All three groups
did not differ on the mood subscale (H(2) = 4.775, p
= .092). Groups also did not differ on the overactivity
(H(2) = 4.807, p = .090) or impulsive speech (H(2) =
5.747, p = .057) subscales of the TAQ. Individuals with
SMS were however found to be more impulsive on this
measure than individuals with PTLS (U(1) = 256.50, Z =
− 3.573, p < .001) but not individuals with idiopathic
ASD (U(1) = 363.50, Z = − 1.998, p = .046). Individuals
with PTLS did not differ from those with idiopathic
ASD (U(1) = 444.00, Z = − 1.470, p = .142).
Discussion
This study aimed to delineate the behavioural profile of
PTLS via comparisons with age- and ability-matched
SMS and idiopathic ASD comparison groups. Selection
of these comparison groups was motivated by the exist-
ing PTLS literature, which suggests (1) variable rates of
ASD behaviours are reported in individuals with PTLS
[1, 14] and (2) aspects of the behavioural profiles of
PTLS and SMS may be diametric mirror traits [28], as
the PTLS duplication is the reciprocal recombination
product of the SMS microdeletion.
On the ASD symptomatology measure, individuals
with idiopathic ASD showed greater impairment on the
Table 2 Percentage of individuals meeting the SCQ cut-off



















.001 ASD > PTLS,
SMS
aSCQ data were incomplete for three individuals with SMS, and therefore, SCQ
total scores could not be calculated
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reciprocal social interaction and communication sub-
scales than individuals with PTLS or SMS, but there
were no group differences on the restricted, repetitive
and stereotyped behaviour subscale. Therefore, the pro-
file of ASD behaviours in PTLS may not be charac-
terised by social interaction and communication deficits
but, as in SMS [17, 22, 32], is more likely to be charac-
terised by restricted, repetitive and stereotyped behav-
iours. Variability in the prevalence of ASD behaviours in
the literature [1, 14, 42, 55] may be explained in part by
the commonality of speech and language deficits in
PTLS, as opposed to specific social deficits associated
with ASD per se, or that generally, ASD behaviours in
individuals with genetic syndromes are more variable
than in individuals with idiopathic ASD [48, 56].
Our preliminary analyses revealed that this uneven
profile of ASD behaviours may be characterised by com-
pulsive repetitive behaviours in PTLS. This is in contrast
to the profile of repetitive behaviours in SMS, which are
not typically defined by compulsive behaviours [48] but
are instead characterised by repetitive topographies of
behaviour such as preference for routine [21, 32, 57],
self-hugging [17, 22, 58] and a restricted preference for
adult attention [22, 32–34, 48, 59]. Therefore, further in-
vestigation is required to delineate the profile of repeti-
tive behaviours in individuals with PTLS.
Table 3 Median subscale scores of each behavioural measure and associated cross-syndrome comparisons and post hoc tests
Syndrome group median scores (interquartile range)c Cross-syndrome comparison
Measures PTLS SMS ASD p value Post hoc test
Social Communication Questionnaire
Reciprocal social interaction 4.00 (2.00–7.25) 7.00 (4.00–8.75) 11.00 (8.00–13.00) < .001 ASD > PTLS, SMS
Communicationa 6.75 (4.66–8.03) 6.00 (3.79–8.00) 9.00 (7.00–11.00) < .001 ASD > PTLS, SMS
Restricted, repetitive and stereotyped behaviours 5.00 (3.00–7.00) 5.00 (3.00–6.00) 6.00 (4.00–7.50) .072
Repetitive Behaviour Questionnaire
Stereotyped behaviour 4.00 (0.00–8.00) 8.00 (3.00–11.00) 6.00 (2.50–11.50) .034
Compulsive behaviour 12.00 (2.75–15.25) 2.00 (0.00–5.00) 8.00 (3.00–18.00) < .001 PTLS, ASD > SMS
Insistence on sameness 2.00 (0.00–7.00) 3.00 (1.00–4.00) 5.00 (2.25–8.00) .014
Restricted preferencesa 5.00 (3.50–8.00) 5.00 (4.00–8.00) 4.00 (2.00–8.50) .814
Repetitive speecha 4.00 (2.00–8.00) 6.00 (4.00–9.00) 6.00 (2.00–9.50) .334
Challenging Behaviour Questionnaire
Self-injury severity score 6.50 (4.25–9.00) 7.00 (5.00–9.00) 7.00 (5.00–8.00) .894
Mood, Interest and Pleasure
Questionnaire-Short Form
Mood 21.00 (19.00–23.00) 20.00 (17.00–22.00) 18.00 (17.00–21.00) .092
Interest and pleasureb 17.26 (15.65–18.87) 16.25 (14.47–18.02) 13.71 (12.05–15.38) .008 PTLS > ASD
The Activity Questionnaire
Impulsivity 13.00 (7.75–19.00) 20.00 (16.00–24.00) 19.00 (11.50–21.00) .002 SMS > PTLS
Overactivity 10.00 (5.50–20.50) 16.00 (9.00–27.00) 20.00 (8.00–29.00) .090
Impulsive speecha 4.00 (1.00–5.00) 5.00 (2.00–9.00) 5.00 (3.00–9.50) .057
aSubscales differ depending on verbal ability. Scores are prorated for non-verbal individuals (SCQ communication) or are not scored for non-verbal individuals,
and therefore, the group n differs for these subscales (RBQ restricted preferences, RBQ repetitive speech, TAQ impulsive speech)
bNormally distributed data; therefore, parametric analysis of variance (ANOVA) was conducted (means and 95% confidence intervals reported)
cInterquartile range based on weighted average at 25 and 75 percentiles
Table 4 Prevalence of challenging behaviour within syndrome groups and associated cross-syndrome comparisons and post hoc
tests
Syndrome group Cross-syndrome comparison
% showing behavioura PTLS (N = 34) SMS (N = 31) ASD (N = 33) p value Post hoc test
Self-injury (N) 29.41 (10) 93.55 (29) 39.39 (13) < .001 SMS > PTLS, ASD
Physical aggression (N) 50.00 (17) 67.74 (21) 62.50b (20) .322
Property destruction (N) 23.53 (8) 77.42 (24) 43.75b (14) < .001 SMS > PTLS, ASD
aStereotyped behaviour prevalence from the CBQ not included as repetitive behaviours are discussed as part of the RBQ
bData missing for one individual with ASD. Percentages calculated based on 32 participants
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Challenging behaviours, especially self-injury and
property destruction, did not appear to be as prominent
in PTLS as they are in SMS. Despite this, a substantial
proportion of individuals with PTLS in our study still
exhibited self-injury (29%) and property destruction
(24%). Individuals with SMS also showed greater impul-
sivity compared to individuals with PTLS and idiopathic
ASD. Groups did not differ on scores attained from the
overactivity subscale however. This is not surprising,
given that overactivity has been reported in both PTLS
and SMS populations [1, 14, 17], and behaviours associ-
ated with attention deficit hyperactivity disorder
(ADHD) are common within both syndromes [4, 60, 61].
Overall, the findings of the current study suggest that
the broad profiles of behaviour in PTLS and SMS do not
appear to be diametrically opposed. Although challen-
ging behaviour was less frequent in PTLS than in SMS,
it did still occur. Aggression in PTLS did not differ sig-
nificantly from SMS and was not reported at a lower
rate than the ASD contrast group. Similarly, while it has
been proposed that social functioning may be a mirror
trait in PTLS and SMS [26], there was no evidence for
this in the current study. Instead, the evidence here
seems to suggest the behavioural phenotypes in PTLS
and SMS are distinct [28].
However, one finding that is of note in the context of
mirror traits [27] is the elevated compulsivity in PTLS.
Compulsive behaviour (characterised by over control of
behaviour) can be conceptualised at one end of a
spectrum of behavioural control and impulsivity
(characterised by lack of behavioural control) at the
opposite end. As SMS is associated with elevated im-
pulsivity [58, 62], as also evidenced in the current
study, it is possible that mirror traits in SMS and
PTLS exist in relation to impulsivity and compulsiv-
ity. This suggestion should be treated with caution, as
scores for compulsive behaviour were obtained from a
measure of repetitive behaviour in individuals with
ID, but measuring compulsivity in PTLS does warrant
further investigation.
Despite a number of interesting findings, there are limi-
tations in the present study. As the PTLS group was re-
cruited internationally, direct cognitive assessments of ID,
adaptive functioning or ASD behaviours could not be con-
ducted. This study instead relied on informant-based mea-
sures of behaviour, utilised a screening measure for ASD
(the SCQ [45]) rather than the ‘gold standard’ Autism
Diagnostic Observation Schedule assessment [63] and
used a proxy measure of self-help abilities (the Wessex
Scale [43]). Without analysing the cytogenetic information
of individuals in the PTLS and SMS groups, uncommon
smaller or larger chromosomal aberrations may also have
been present. To investigate mirror trait associations reli-
ably, individuals would need to be matched according to
the size of their chromosomal duplications and deletions.
There were also fewer individuals in the SMS group with
normal hearing and vision compared to the ASD group.
To investigate whether this may have contributed to the
differences identified, individuals with poor hearing and
vision were removed from analyses. Consequently, the dif-
ference between the SMS and PTLS groups in relation to
impulsivity and rates of property destruction between the
SMS and ASD groups became non-significant. However,
the effect size for the property destruction analysis
remained the same (medium) when individuals with poor
hearing and vision were removed, suggesting that these
differences may have become non-significant because of
loss of power as a result of smaller sample sizes, as
opposed to differences in hearing and vision driving the
significant outcomes. In contrast, the impulsivity effect
size reduced from intermediate to small, suggesting that
differences in vision and hearing may have contributed to
the significant result found. Future studies would benefit
from ascertaining larger samples to enable matching on
these characteristics, in addition to age and level of ability.
It is also of note that individuals were not matched
according to gender. Given our modest sample sizes, we
prioritised matching according to age and estimates of
ability rather than gender. The present study therefore
enables profiles of ASD characteristics in PTLS and
SMS to be contrasted to a profile of ASD characteristics
that is representative of the idiopathic ASD population
in which a disproportionate male to female ratio exists.
Our study does not however enable us to compare the
profile of ASD characteristics in PTLS and SMS to indi-
viduals with idiopathic ASD who are matched according
to gender. This is a clear limitation, given that behav-
ioural and neuroanatomical gender differences are
prominently reported in the idiopathic ASD literature
(e.g. reduced gyrification of the ventromedial/orbitofron-
tal prefrontal cortex in males with ASD compared to fe-
males with ASD relating to between-group differences in
social functioning [64] and greater presentation of exter-
nalising and internalising behaviours in males and
females diagnosed with ASD, respectively [65]). In future
research, when larger sample sizes allow for a more
comprehensive matching strategy to be utilised, or when
gender can be included as a covariate in analyses, gender
differences relating to social behaviour should be ex-
plored more thoroughly.
However, the clinical utility of this study’s findings
should not be underestimated. PTLS is a rare and re-
cently recognised syndrome [1]. The current study has
identified likely difficulties around repetitive behaviour,
which may have implications for behaviour management
in this syndrome. For example, some behavioural man-
agement and intervention programmes for ASD, which
specifically target social deficits (e.g. Reciprocal
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Imitation Training [66]), may not be wholly appropriate
for individuals with PTLS. Therefore, the clinical impli-
cations of delineating the behavioural phenotype of
PTLS are of particular benefit to caregivers and
professionals.
Conclusions
Both individuals with PTLS and SMS showed less impair-
ment on SCQ subscales measuring reciprocal social inter-
action and communication, which suggests the profile of
ASD behaviours in these syndrome groups does not
match the ‘typical’ ASD behaviour profile in idiopathic
ASD. Individuals with PTLS or idiopathic ASD showed
more compulsive behaviour than those with SMS. Finally,
along with individuals with idiopathic ASD, individuals
with PTLS were rated as less impulsive and as showing
less self-injury and property destruction by their caregivers
than individuals with SMS. The profile of ASD behaviours
and repetitive behaviours in PTLS therefore requires fur-
ther exploration. Little evidence for mirror traits in PTLS
and SMS emerged in the present study, although a pos-
sible compulsivity/impulsivity mirror trait warrants fur-
ther investigation.
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